Low Glycemic Diet for Type 2 Diabetes

Phase-Based Progress Estimates
The University of Alabama at Birmingham, Birmingham, ALType 2 DiabetesLow Glycemic Diet - Other
35 - 65
All Sexes
What conditions do you have?

Study Summary

This trial is testing the hypothesis that reducing dietary glycemic load will decrease pancreas lipid and improve beta-cell function in patients with early Type 2 Diabetes, especially African-Americans.

Eligible Conditions
  • Type 2 Diabetes

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 12 weeks

12 weeks
Insulin secretion
Pancreas lipid

Trial Safety

Trial Design

2 Treatment Groups

Low Glycemic Diet
1 of 2
Control Diet
1 of 2

Experimental Treatment

Non-Treatment Group

80 Total Participants · 2 Treatment Groups

Primary Treatment: Low Glycemic Diet · Has Placebo Group · N/A

Low Glycemic Diet
Experimental Group · 1 Intervention: Low Glycemic Diet · Intervention Types: Other
Control Diet
PlaceboComparator Group · 1 Intervention: Control Diet · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,445 Previous Clinical Trials
2,235,416 Total Patients Enrolled

Eligibility Criteria

Age 35 - 65 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are either African American or European American.

Frequently Asked Questions

How many participants have been recruited into this clinical investigation?

"Affirmative. Clinicaltrials.gov data shows that this medical experiment, which was initially posted on October 9th 2018 is still recruiting participants. It necessitates 80 individuals from a single clinic to be enrolled in the trial." - Anonymous Online Contributor

Unverified Answer

Are individuals of advanced age being enrolled in this trial?

"The current recruitment process is targeting adults between the ages of 35 and 65." - Anonymous Online Contributor

Unverified Answer

To which demographic is this research endeavor open?

"This medical experiment is welcoming 80 individuals with type 2 diabetes between the ages of 35 and 65. The primary eligibility requirements are as follows: Diagnosed within the last decade, treated using dietary changes or metformin/DPP-IV inhibitors, aged 35 to 65 years old, Hemoglobin A1c <7.0, African American or European American racial background, BMI 25-45 kg/m2 (no more than 5kg change in past 6 months)." - Anonymous Online Contributor

Unverified Answer

Is recruitment for this clinical trial still open?

"Affirmative. Clinicaltrials.gov verifies that this study is presently seeking enrollees and was first advertised on October 9th, 2018 with its most recent update occurring April 6th 2022. The experiment requires 80 volunteers to be registered at 1 medical facility." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.